Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Non-opioid Pain Patches Market Growth 2022-2028

  • LP 4836267
  • 107 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Non-opioid Pain Patches will have significant change from previous year. According to our (LP Information) latest study, the global Non-opioid Pain Patches market size is USD million in 2022 from USD 617.6 million in 2021, with a change of % between 2021 and 2022. The global Non-opioid Pain Patches market size will reach USD 744.1 million in 2028, growing at a CAGR of 2.7% over the analysis period.

The United States Non-opioid Pain Patches market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-opioid Pain Patches market, reaching US$ million by the year 2028. As for the Europe Non-opioid Pain Patches landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Non-opioid Pain Patches players cover Pfizer, GlaxoSmithKline, Johnson & Johnson, and Novartis AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patches market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Lidocaine Patch

Diclofenac Patch

Methyl Salicylate Patch

Capsaicin Patch

Ketoprofen Patch

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Independent Pharmacies & Drug Stores

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

GlaxoSmithKline

Johnson & Johnson

Novartis AG

Mylan N.V.

Teva Pharmaceutical Industries

Hisamitsu Pharmaceutical

TEH SENG Pharmaceutical

Teikoku Seiyaku

IBSA Institut Biochimque SA

Acorda Therapeutics

Allergan PLC

Endo International

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-opioid Pain Patches Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Non-opioid Pain Patches by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Non-opioid Pain Patches by Country/Region, 2017, 2022 & 2028

2.2 Non-opioid Pain Patches Segment by Type

2.2.1 Lidocaine Patch

2.2.2 Diclofenac Patch

2.2.3 Methyl Salicylate Patch

2.2.4 Capsaicin Patch

2.2.5 Ketoprofen Patch

2.2.6 Others

2.3 Non-opioid Pain Patches Sales by Type

2.3.1 Global Non-opioid Pain Patches Sales Market Share by Type (2017-2022)

2.3.2 Global Non-opioid Pain Patches Revenue and Market Share by Type (2017-2022)

2.3.3 Global Non-opioid Pain Patches Sale Price by Type (2017-2022)

2.4 Non-opioid Pain Patches Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Independent Pharmacies & Drug Stores

2.4.3 Online Pharmacies

2.5 Non-opioid Pain Patches Sales by Application

2.5.1 Global Non-opioid Pain Patches Sale Market Share by Application (2017-2022)

2.5.2 Global Non-opioid Pain Patches Revenue and Market Share by Application (2017-2022)

2.5.3 Global Non-opioid Pain Patches Sale Price by Application (2017-2022)

3 Global Non-opioid Pain Patches by Company

3.1 Global Non-opioid Pain Patches Breakdown Data by Company

3.1.1 Global Non-opioid Pain Patches Annual Sales by Company (2020-2022)

3.1.2 Global Non-opioid Pain Patches Sales Market Share by Company (2020-2022)

3.2 Global Non-opioid Pain Patches Annual Revenue by Company (2020-2022)

3.2.1 Global Non-opioid Pain Patches Revenue by Company (2020-2022)

3.2.2 Global Non-opioid Pain Patches Revenue Market Share by Company (2020-2022)

3.3 Global Non-opioid Pain Patches Sale Price by Company

3.4 Key Manufacturers Non-opioid Pain Patches Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Non-opioid Pain Patches Product Location Distribution

3.4.2 Players Non-opioid Pain Patches Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Non-opioid Pain Patches by Geographic Region

4.1 World Historic Non-opioid Pain Patches Market Size by Geographic Region (2017-2022)

4.1.1 Global Non-opioid Pain Patches Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Non-opioid Pain Patches Annual Revenue by Geographic Region

4.2 World Historic Non-opioid Pain Patches Market Size by Country/Region (2017-2022)

4.2.1 Global Non-opioid Pain Patches Annual Sales by Country/Region (2017-2022)

4.2.2 Global Non-opioid Pain Patches Annual Revenue by Country/Region

4.3 Americas Non-opioid Pain Patches Sales Growth

4.4 APAC Non-opioid Pain Patches Sales Growth

4.5 Europe Non-opioid Pain Patches Sales Growth

4.6 Middle East & Africa Non-opioid Pain Patches Sales Growth

5 Americas

5.1 Americas Non-opioid Pain Patches Sales by Country

5.1.1 Americas Non-opioid Pain Patches Sales by Country (2017-2022)

5.1.2 Americas Non-opioid Pain Patches Revenue by Country (2017-2022)

5.2 Americas Non-opioid Pain Patches Sales by Type

5.3 Americas Non-opioid Pain Patches Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-opioid Pain Patches Sales by Region

6.1.1 APAC Non-opioid Pain Patches Sales by Region (2017-2022)

6.1.2 APAC Non-opioid Pain Patches Revenue by Region (2017-2022)

6.2 APAC Non-opioid Pain Patches Sales by Type

6.3 APAC Non-opioid Pain Patches Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Non-opioid Pain Patches by Country

7.1.1 Europe Non-opioid Pain Patches Sales by Country (2017-2022)

7.1.2 Europe Non-opioid Pain Patches Revenue by Country (2017-2022)

7.2 Europe Non-opioid Pain Patches Sales by Type

7.3 Europe Non-opioid Pain Patches Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-opioid Pain Patches by Country

8.1.1 Middle East & Africa Non-opioid Pain Patches Sales by Country (2017-2022)

8.1.2 Middle East & Africa Non-opioid Pain Patches Revenue by Country (2017-2022)

8.2 Middle East & Africa Non-opioid Pain Patches Sales by Type

8.3 Middle East & Africa Non-opioid Pain Patches Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Non-opioid Pain Patches

10.3 Manufacturing Process Analysis of Non-opioid Pain Patches

10.4 Industry Chain Structure of Non-opioid Pain Patches

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Non-opioid Pain Patches Distributors

11.3 Non-opioid Pain Patches Customer

12 World Forecast Review for Non-opioid Pain Patches by Geographic Region

12.1 Global Non-opioid Pain Patches Market Size Forecast by Region

12.1.1 Global Non-opioid Pain Patches Forecast by Region (2023-2028)

12.1.2 Global Non-opioid Pain Patches Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Non-opioid Pain Patches Forecast by Type

12.7 Global Non-opioid Pain Patches Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Non-opioid Pain Patches Product Offered

13.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Non-opioid Pain Patches Product Offered

13.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Company Information

13.3.2 Johnson & Johnson Non-opioid Pain Patches Product Offered

13.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Main Business Overview

13.3.5 Johnson & Johnson Latest Developments

13.4 Novartis AG

13.4.1 Novartis AG Company Information

13.4.2 Novartis AG Non-opioid Pain Patches Product Offered

13.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis AG Main Business Overview

13.4.5 Novartis AG Latest Developments

13.5 Mylan N.V.

13.5.1 Mylan N.V. Company Information

13.5.2 Mylan N.V. Non-opioid Pain Patches Product Offered

13.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Mylan N.V. Main Business Overview

13.5.5 Mylan N.V. Latest Developments

13.6 Teva Pharmaceutical Industries

13.6.1 Teva Pharmaceutical Industries Company Information

13.6.2 Teva Pharmaceutical Industries Non-opioid Pain Patches Product Offered

13.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teva Pharmaceutical Industries Main Business Overview

13.6.5 Teva Pharmaceutical Industries Latest Developments

13.7 Hisamitsu Pharmaceutical

13.7.1 Hisamitsu Pharmaceutical Company Information

13.7.2 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Offered

13.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hisamitsu Pharmaceutical Main Business Overview

13.7.5 Hisamitsu Pharmaceutical Latest Developments

13.8 TEH SENG Pharmaceutical

13.8.1 TEH SENG Pharmaceutical Company Information

13.8.2 TEH SENG Pharmaceutical Non-opioid Pain Patches Product Offered

13.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 TEH SENG Pharmaceutical Main Business Overview

13.8.5 TEH SENG Pharmaceutical Latest Developments

13.9 Teikoku Seiyaku

13.9.1 Teikoku Seiyaku Company Information

13.9.2 Teikoku Seiyaku Non-opioid Pain Patches Product Offered

13.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Teikoku Seiyaku Main Business Overview

13.9.5 Teikoku Seiyaku Latest Developments

13.10 IBSA Institut Biochimque SA

13.10.1 IBSA Institut Biochimque SA Company Information

13.10.2 IBSA Institut Biochimque SA Non-opioid Pain Patches Product Offered

13.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 IBSA Institut Biochimque SA Main Business Overview

13.10.5 IBSA Institut Biochimque SA Latest Developments

13.11 Acorda Therapeutics

13.11.1 Acorda Therapeutics Company Information

13.11.2 Acorda Therapeutics Non-opioid Pain Patches Product Offered

13.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Acorda Therapeutics Main Business Overview

13.11.5 Acorda Therapeutics Latest Developments

13.12 Allergan PLC

13.12.1 Allergan PLC Company Information

13.12.2 Allergan PLC Non-opioid Pain Patches Product Offered

13.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Allergan PLC Main Business Overview

13.12.5 Allergan PLC Latest Developments

13.13 Endo International

13.13.1 Endo International Company Information

13.13.2 Endo International Non-opioid Pain Patches Product Offered

13.13.3 Endo International Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Endo International Main Business Overview

13.13.5 Endo International Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Non-opioid Pain Patches Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Non-opioid Pain Patches Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lidocaine Patch

Table 4. Major Players of Diclofenac Patch

Table 5. Major Players of Methyl Salicylate Patch

Table 6. Major Players of Capsaicin Patch

Table 7. Major Players of Ketoprofen Patch

Table 8. Major Players of Others

Table 9. Global Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Non-opioid Pain Patches Sales Market Share by Type (2017-2022)

Table 11. Global Non-opioid Pain Patches Revenue by Type (2017-2022) & ($ million)

Table 12. Global Non-opioid Pain Patches Revenue Market Share by Type (2017-2022)

Table 13. Global Non-opioid Pain Patches Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Non-opioid Pain Patches Sales Market Share by Application (2017-2022)

Table 16. Global Non-opioid Pain Patches Revenue by Application (2017-2022)

Table 17. Global Non-opioid Pain Patches Revenue Market Share by Application (2017-2022)

Table 18. Global Non-opioid Pain Patches Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Non-opioid Pain Patches Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Non-opioid Pain Patches Sales Market Share by Company (2020-2022)

Table 21. Global Non-opioid Pain Patches Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Non-opioid Pain Patches Revenue Market Share by Company (2020-2022)

Table 23. Global Non-opioid Pain Patches Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Non-opioid Pain Patches Producing Area Distribution and Sales Area

Table 25. Players Non-opioid Pain Patches Products Offered

Table 26. Non-opioid Pain Patches Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Non-opioid Pain Patches Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Non-opioid Pain Patches Sales Market Share Geographic Region (2017-2022)

Table 31. Global Non-opioid Pain Patches Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Non-opioid Pain Patches Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Non-opioid Pain Patches Sales Market Share by Country/Region (2017-2022)

Table 35. Global Non-opioid Pain Patches Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Non-opioid Pain Patches Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Non-opioid Pain Patches Sales Market Share by Country (2017-2022)

Table 39. Americas Non-opioid Pain Patches Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Non-opioid Pain Patches Revenue Market Share by Country (2017-2022)

Table 41. Americas Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Non-opioid Pain Patches Sales Market Share by Type (2017-2022)

Table 43. Americas Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Non-opioid Pain Patches Sales Market Share by Application (2017-2022)

Table 45. APAC Non-opioid Pain Patches Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Non-opioid Pain Patches Sales Market Share by Region (2017-2022)

Table 47. APAC Non-opioid Pain Patches Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Non-opioid Pain Patches Revenue Market Share by Region (2017-2022)

Table 49. APAC Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Non-opioid Pain Patches Sales Market Share by Type (2017-2022)

Table 51. APAC Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Non-opioid Pain Patches Sales Market Share by Application (2017-2022)

Table 53. Europe Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Non-opioid Pain Patches Sales Market Share by Country (2017-2022)

Table 55. Europe Non-opioid Pain Patches Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Non-opioid Pain Patches Revenue Market Share by Country (2017-2022)

Table 57. Europe Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Non-opioid Pain Patches Sales Market Share by Type (2017-2022)

Table 59. Europe Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Non-opioid Pain Patches Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Non-opioid Pain Patches Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Non-opioid Pain Patches Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Non-opioid Pain Patches

Table 70. Key Market Challenges & Risks of Non-opioid Pain Patches

Table 71. Key Industry Trends of Non-opioid Pain Patches

Table 72. Non-opioid Pain Patches Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Non-opioid Pain Patches Distributors List

Table 75. Non-opioid Pain Patches Customer List

Table 76. Global Non-opioid Pain Patches Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Non-opioid Pain Patches Sales Market Forecast by Region

Table 78. Global Non-opioid Pain Patches Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Non-opioid Pain Patches Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Non-opioid Pain Patches Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Non-opioid Pain Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Non-opioid Pain Patches Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Non-opioid Pain Patches Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Non-opioid Pain Patches Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Non-opioid Pain Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Non-opioid Pain Patches Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Non-opioid Pain Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Non-opioid Pain Patches Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Non-opioid Pain Patches Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Non-opioid Pain Patches Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Non-opioid Pain Patches Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Non-opioid Pain Patches Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Non-opioid Pain Patches Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Non-opioid Pain Patches Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Non-opioid Pain Patches Revenue Market Share Forecast by Application (2023-2028)

Table 96. Pfizer Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 97. Pfizer Non-opioid Pain Patches Product Offered

Table 98. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Pfizer Main Business

Table 100. Pfizer Latest Developments

Table 101. GlaxoSmithKline Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 102. GlaxoSmithKline Non-opioid Pain Patches Product Offered

Table 103. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. GlaxoSmithKline Main Business

Table 105. GlaxoSmithKline Latest Developments

Table 106. Johnson & Johnson Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 107. Johnson & Johnson Non-opioid Pain Patches Product Offered

Table 108. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Johnson & Johnson Main Business

Table 110. Johnson & Johnson Latest Developments

Table 111. Novartis AG Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 112. Novartis AG Non-opioid Pain Patches Product Offered

Table 113. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Novartis AG Main Business

Table 115. Novartis AG Latest Developments

Table 116. Mylan N.V. Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 117. Mylan N.V. Non-opioid Pain Patches Product Offered

Table 118. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Mylan N.V. Main Business

Table 120. Mylan N.V. Latest Developments

Table 121. Teva Pharmaceutical Industries Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 122. Teva Pharmaceutical Industries Non-opioid Pain Patches Product Offered

Table 123. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Teva Pharmaceutical Industries Main Business

Table 125. Teva Pharmaceutical Industries Latest Developments

Table 126. Hisamitsu Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 127. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Offered

Table 128. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Hisamitsu Pharmaceutical Main Business

Table 130. Hisamitsu Pharmaceutical Latest Developments

Table 131. TEH SENG Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 132. TEH SENG Pharmaceutical Non-opioid Pain Patches Product Offered

Table 133. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. TEH SENG Pharmaceutical Main Business

Table 135. TEH SENG Pharmaceutical Latest Developments

Table 136. Teikoku Seiyaku Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 137. Teikoku Seiyaku Non-opioid Pain Patches Product Offered

Table 138. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Teikoku Seiyaku Main Business

Table 140. Teikoku Seiyaku Latest Developments

Table 141. IBSA Institut Biochimque SA Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 142. IBSA Institut Biochimque SA Non-opioid Pain Patches Product Offered

Table 143. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. IBSA Institut Biochimque SA Main Business

Table 145. IBSA Institut Biochimque SA Latest Developments

Table 146. Acorda Therapeutics Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 147. Acorda Therapeutics Non-opioid Pain Patches Product Offered

Table 148. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. Acorda Therapeutics Main Business

Table 150. Acorda Therapeutics Latest Developments

Table 151. Allergan PLC Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 152. Allergan PLC Non-opioid Pain Patches Product Offered

Table 153. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 154. Allergan PLC Main Business

Table 155. Allergan PLC Latest Developments

Table 156. Endo International Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors

Table 157. Endo International Non-opioid Pain Patches Product Offered

Table 158. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 159. Endo International Main Business

Table 160. Endo International Latest Developments

List of Figures

Figure 1. Picture of Non-opioid Pain Patches

Figure 2. Non-opioid Pain Patches Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Non-opioid Pain Patches Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Non-opioid Pain Patches Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Non-opioid Pain Patches Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lidocaine Patch

Figure 10. Product Picture of Diclofenac Patch

Figure 11. Product Picture of Methyl Salicylate Patch

Figure 12. Product Picture of Capsaicin Patch

Figure 13. Product Picture of Ketoprofen Patch

Figure 14. Product Picture of Others

Figure 15. Global Non-opioid Pain Patches Sales Market Share by Type in 2021

Figure 16. Global Non-opioid Pain Patches Revenue Market Share by Type (2017-2022)

Figure 17. Non-opioid Pain Patches Consumed in Hospital Pharmacies

Figure 18. Global Non-opioid Pain Patches Market: Hospital Pharmacies (2017-2022) & (K Pcs)

Figure 19. Non-opioid Pain Patches Consumed in Independent Pharmacies & Drug Stores

Figure 20. Global Non-opioid Pain Patches Market: Independent Pharmacies & Drug Stores (2017-2022) & (K Pcs)

Figure 21. Non-opioid Pain Patches Consumed in Online Pharmacies

Figure 22. Global Non-opioid Pain Patches Market: Online Pharmacies (2017-2022) & (K Pcs)

Figure 23. Global Non-opioid Pain Patches Sales Market Share by Application (2017-2022)

Figure 24. Global Non-opioid Pain Patches Revenue Market Share by Application in 2021

Figure 25. Non-opioid Pain Patches Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Non-opioid Pain Patches Revenue Market Share by Company in 2021

Figure 27. Global Non-opioid Pain Patches Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region in 2021

Figure 29. Global Non-opioid Pain Patches Sales Market Share by Region (2017-2022)

Figure 30. Global Non-opioid Pain Patches Revenue Market Share by Country/Region in 2021

Figure 31. Americas Non-opioid Pain Patches Sales 2017-2022 (K Pcs)

Figure 32. Americas Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)

Figure 33. APAC Non-opioid Pain Patches Sales 2017-2022 (K Pcs)

Figure 34. APAC Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)

Figure 35. Europe Non-opioid Pain Patches Sales 2017-2022 (K Pcs)

Figure 36. Europe Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Non-opioid Pain Patches Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)

Figure 39. Americas Non-opioid Pain Patches Sales Market Share by Country in 2021

Figure 40. Americas Non-opioid Pain Patches Revenue Market Share by Country in 2021

Figure 41. United States Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Non-opioid Pain Patches Sales Market Share by Region in 2021

Figure 46. APAC Non-opioid Pain Patches Revenue Market Share by Regions in 2021

Figure 47. China Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Non-opioid Pain Patches Sales Market Share by Country in 2021

Figure 54. Europe Non-opioid Pain Patches Revenue Market Share by Country in 2021

Figure 55. Germany Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Non-opioid Pain Patches Revenue Market Share by Country in 2021

Figure 62. Egypt Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Non-opioid Pain Patches in 2021

Figure 68. Manufacturing Process Analysis of Non-opioid Pain Patches

Figure 69. Industry Chain Structure of Non-opioid Pain Patches

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390